Country/territory-wise SARS-CoV-2 lineage distributions of 13,627,121 genomes from GISAID (up to June 22, 2024) based on the combinations of bases at 206 marker sites and variants of concern (VOCs) defining mutation sites. In total 15,268,436 genomes were retrieved from GISAID (as of June 22, 2024), 13,627,121 genomes were used in the analysis after quality control. Criteria for quality control : 1) Ns < 5%; 2) length > 29,000 after removing Ns.
Estimation of the reproduction number (R) and prediction of the infected population of SARS-CoV-2 for each country by fitting a Susceptible, Un-quanrantined infected, Quarantined infected, Confirmed infected (SUQC) model.
A tool for assigning SARS-CoV-2 genomes into defined lineages based on the combinations of bases at 206 marker sites and variants of concern (VOCs) defining mutation sites.
Summary of global dynamics of COVID-19 pandemic, including the cumulative confirmed cases, daily confirmed cases, active confirmed cases, deaths, and matality for each country.
Visualizing variant sites (29,893 in total, degenerate bases excluded) in 13,627,121 SARS-CoV-2 genomes from GISAID (up to June 22, 2024). Quality control: 1) Ns < 5%; 2) length > 29,000 after removing Ns.